Skip to main content

Jasmine

Analyst

UBS

Equibles does not estimate personal net worth.

About Jasmine

Jasmine is recorded as Analyst at UBS. Jasmine has spoken on 2 earnings calls across 1 company, most recently for Biomarin Pharmaceutical Inc on August 4, 2025. The companies whose calls Jasmine spoke on are classified in the Healthcare sector.

Jasmine on recent calls

“So, what's the latest on timing for evoxogo and other growth disorders like ISS and SHOX? And then how quickly do you think that you could move 333 here? So would you want to wait for Vox Ogo clinical success here before studying 333 in these indications, or is that something you'd want to do sooner?”
Analyst — UBS, Biomarin Pharmaceutical Inc Q1 FY2025 Earnings Call ·

Affiliation history

  • UBS

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity